SCHEMBL18722706

SCHEMBL18722706

O=C(S)NCc1cccc(O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
PKM P14618 1/20 0.56
ALOX15 P16050 1/20 0.56
NFKB1 P19838 1/20 0.56
MAPK1 P28482 1/20 0.56
KMT2A Q03164 1/20 0.55
KDM4E B2RXH2 1/20 0.55
LMNA P02545 1/20 0.55
MAPT P10636 1/20 0.55
BLM P54132 1/20 0.55
PMP22 Q01453 1/20 0.55
ROCK2 O75116 2/20 0.52
ROCK1 Q13464 2/20 0.52
SRC P12931 1/20 0.51
GABRP O00591 1/20 0.49
GABRD O14764 1/20 0.49
GABRA1 P14867 1/20 0.49
GABRB1 P18505 1/20 0.49
GABRG2 P18507 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2806074 0.83 CYP1A2 (0.59) CYP1A2CYP3A4PKMALOX15NFKB1
SCHEMBL31724652 0.81 CYP1A2 (0.56) CYP1A2CYP3A4PKMALOX15NFKB1
SCHEMBL5725833 0.81 CYP1A2 (0.56) CYP1A2CYP3A4PKMALOX15NFKB1
SCHEMBL358332 0.81 CYP1A2 (0.61) CYP1A2CYP3A4PKMALOX15NFKB1
SCHEMBL18722262 0.80 SRC (0.56) MAPK1LMNASRCALDH1A1HPGD
SCHEMBL9416647 0.79 ROCK2 (0.65) CYP1A2CYP3A4PKMALOX15NFKB1
SCHEMBL934634 0.79 CYP3A4 (0.53) CYP1A2CYP3A4PKMALOX15NFKB1
SCHEMBL22026435 0.79 CYP1A2 (0.62) CYP1A2CYP3A4PKMALOX15NFKB1
SCHEMBL14289839 0.79 CYP1A2 (0.53) CYP1A2CYP3A4PKMALOX15NFKB1
SCHEMBL8480688 0.79 PKM (0.53) CYP1A2CYP3A4PKMALOX15NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9616064-B2 Rho kinase inhibitors and methods of use H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2017-04-11 US disclosed